An emerging dyslipidemia: Assessing future CV risk in children

Article

Studies have provided new information that increased triglycerides and low HDL cholesterol associated with childhood obesity are risk factors for cardiovascular disease in young adulthood.

Key Points

New research on the natural history of familial hypercholesterolemia, a genetic disorder present in 1/500 of the general population, has demonstrated the adverse effects of chronic long-term exposure to elevated low-density lipoprotein (LDL) cholesterol and has prompted new recommendations regarding its management.1

In addition to cholesterol, and as a consequence of the obesity epidemic, triglycerides have emerged as an important lipid risk factor.

The renewed recognition of the importance of early life experiences to future cardiovascular disease has led to the development of the Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, evidence-based guidelines on the management of lipid disorders in children.2,3

Dyslipidemia and atherosclerosis

The demonstration of the relationship of cardiovascular risk factors measured post mortem to atherosclerosis in adolescents in the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study has been instrumental in justifying preventive cardiology efforts in childhood.4

Analyses from the PDAY study have calculated that for every increase of 30 mg/dL of non-high-density lipoprotein (HDL) cholesterol, there is a significant increase in premature atherosclerosis measured in the coronary arteries and abdominal aorta.

Lower HDL cholesterol also contributes to premature atherosclerosis. This is true for the earliest lesions of atherosclerosis (fatty streaks) seen in adolescence and for advanced lesions seen in young adulthood.

Most important, the presence of several cardiovascular risk factors in the same person accelerates the process.

Related Videos
Perry Roy, MD | Image Credit: Carolina Attention Specialists
Angela Nash, PhD, APRN, CPNP-PC, PMHS | Image credit: UTHealth Houston
Allison Scott, DNP, CPNP-PC, IBCLC
Joanne M. Howard, MSN, MA, RN, CPNP-PC, PMHS & Anne Craig, MSN, RN, CPNP-PC
Juanita Mora, MD
Natasha Hoyte, MPH, CPNP-PC
Lauren Flagg
Venous thromboembolism, Heparin-induced thrombocytopenia, and direct oral anticoagulants | Image credit: Contemporary Pediatrics
Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
Sally Humphrey, DNP, APRN, CPNP-PC | Image Credit: Contemporary Pediatrics
© 2024 MJH Life Sciences

All rights reserved.